Well Lead Medical Valuation

Q: What is the Fair Price of 603309 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

603309 (CN¥13.03) is trading above our estimate of [[fair value]] (CN¥12.06)

Is 603309 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 603309 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 603309 (CN¥13.03) is trading above our estimate of fair value (CN¥12.06)

Significantly Below Fair Value: 603309 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 603309?

Key metric: As 603309 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 603309. This is calculated by dividing 603309's market cap by their current earnings.
What is 603309's PE Ratio?
PE Ratio	17.7x
Earnings	CN¥215.29m
Market Cap	CN¥3.82b

603309 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.7x
Enterprise Value/EBITDA	13.1x
PEG Ratio	0.8x

Price to Earnings Ratio vs Peers

How does 603309's PE Ratio compare to its peers?

The above table shows the PE ratio for 603309 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	27.8x
300453 Jiangxi Sanxin MedtecLtd	17.6x	n/a	CN¥4.1b
688338 Beijing Succeeder Technology	26x	21.2%	CN¥2.9b
301580 Aidite (Qinhuangdao) Technology	26.9x	n/a	CN¥4.3b
603205 Jianerkang Medical	40.9x	n/a	CN¥5.5b
603309 Well Lead Medical	17.7x	20.9%	CN¥3.8b

Price-To-Earnings vs Peers: 603309 is good value based on its Price-To-Earnings Ratio (17.7x) compared to the peer average (27.8x).

Price to Earnings Ratio vs Industry

How does 603309's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 603309 is good value based on its Price-To-Earnings Ratio (17.7x) compared to the CN Medical Equipment industry average (34.5x).

Price to Earnings Ratio vs Fair Ratio

What is 603309's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

603309 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	17.7x
Fair PE Ratio	23.6x

Price-To-Earnings vs Fair Ratio: 603309 is good value based on its Price-To-Earnings Ratio (17.7x) compared to the estimated Fair Price-To-Earnings Ratio (23.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.7b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.53

-5.8%

-34.9%

Chison Medical Technologies

CN¥2.7b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥24.06

-8.2%

-44.8%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.72

-2.1%

28.8%